2-methyl-1-[(oxiran-2-yl)methyl]piperidine, 95.0%, 2g

4-aminobenzonitrile, min. 98%, for synthesis, 10 g, plastic packaging.

2-(4-Bromo-3-methyl-pyrazol-1-yl)-propionic acid, 95.0%, 1g

2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250g

2-Chloro-5-fluoro-3-(trifluoromethyl)phenylboronic acid, 95%, 500mg

5-(2,5-Dimethylphenoxy)pentanoic acid, 97%, 10g

Benzo[d]thiazole-2-carbonitrile, 95.0%, 10g

1-(2-Bromoethyl)-3,5-dichlorobenzene, 95%, 5g

Potassium p-Toluenethiosulfonate>98.0%(HPLC)25g

4-(2-Cyanopropan-2-yl)picolinic acid, 98%, 250mg

6-Fluoro-7-nitroquinoxaline, 98%, 100mg

1-Ethyl-3-methylimidazolium ethyl sulfate, 99.0%, 25g

2,3,6,7,10,11-Hexabromotriphenylene, 98%, 5g